149 related articles for article (PubMed ID: 38164269)
21. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
Wang L; Ke Q; Lin N; Zeng Y; Liu J
Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401
[No Abstract] [Full Text] [Related]
22. A reasonable identification of the early recurrence time based on microvascular invasion for hepatocellular carcinoma after R0 resection: A multicenter retrospective study.
Liu ZH; Chai ZT; Feng JK; Hou YC; Zhang XP; Chen ZH; Xiang YJ; Guo WX; Shi J; Cheng SQ
Cancer Med; 2023 May; 12(9):10294-10302. PubMed ID: 36880150
[TBL] [Abstract][Full Text] [Related]
23. Postoperative adjuvant transarterial chemoembolization for intrahepatic cholangiocarcinoma patients with microvascular invasion: a propensity score analysis.
Cheng Z; Lei Z; Jin X; Zhang Q; Si A; Yang P; Zhou J; Hartmann D; Hüser N; Shen F
J Gastrointest Oncol; 2021 Apr; 12(2):819-830. PubMed ID: 34012669
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of Adjuvant Transarterial Chemoembolization Combined Antiviral Therapy for HBV-Related HCC with MVI after Hepatic Resection: A Multicenter Study.
Tang Y; Zhang J; Chen G; Zeng J; Zeng J
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2695-2703. PubMed ID: 36037123
[TBL] [Abstract][Full Text] [Related]
25. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion.
Wang L; Wang W; Yao X; Rong W; Wu F; Chen B; Liu M; Lin S; Liu Y; Wu J
Oncotarget; 2017 Oct; 8(45):79971-79981. PubMed ID: 29108379
[TBL] [Abstract][Full Text] [Related]
26. Impact of pathological response after preoperative transcatheter arterial chemoembolization (TACE) on incidences of microvascular invasion and early tumor recurrence in hepatocellular carcinoma: a multicenter propensity score matching analysis.
Yang Y; Dang Z; Lu P; Qian Y; Lin K; Pan Z; Lau WY; Zhou W
Hepatobiliary Surg Nutr; 2022 Jun; 11(3):386-399. PubMed ID: 35693405
[TBL] [Abstract][Full Text] [Related]
27. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Survival Analysis of Transarterial Chemoembolization Plus Radiotherapy vs. Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion.
Su TS; Li LQ; Meng WW; Wang YD; Chen YT; Li JX; Du YQ; Qu S; Zhao C; Huang DJ; Liang SX; Li LQ
Front Oncol; 2020; 10():1205. PubMed ID: 32850352
[No Abstract] [Full Text] [Related]
29. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
30. Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
Yang SY; Yan ML; Duan YF; Feng JK; Ye JZ; Xiang YJ; Liu ZH; Guo L; Xue J; Cheng SQ; Guo WX
Hepatol Int; 2022 Aug; 16(4):892-905. PubMed ID: 35704267
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and Safety of Central Memory T Cells Combined With Adjuvant Therapy to Prevent Recurrence of Hepatocellular Carcinoma With Microvascular Invasion: A Pilot Study.
Cai J; Zhao J; Liu D; Xie H; Qi H; Ma J; Sun Z; Zhao H
Front Oncol; 2021; 11():781029. PubMed ID: 34926296
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Adjuvant Transarterial Chemoembolization after Radical Hepatectomy in Solitary Hepatocellular Carcinoma Patients: A Retrospective Study.
Zeng G; Zou B; Li Y; Lin E; Liu X; Li P; Chen J; Zhang B; Jia Y; Cai C; Li J
J Invest Surg; 2022 Jun; 35(6):1208-1216. PubMed ID: 35078386
[No Abstract] [Full Text] [Related]
33. Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy.
Xiao H; Chen ZB; Jin HL; Li B; Xu LX; Guo Y; Chen SL; Li HP; Peng ZW; Shen JX
Am J Transl Res; 2019; 11(3):1864-1875. PubMed ID: 30972210
[TBL] [Abstract][Full Text] [Related]
34. Survival benefit from adjuvant TACE combined with Lenvatinib for patients with hepatocellular carcinoma and microvascular invasion after curative hepatectomy.
Liang L; Xu ZD; Lu WF; Du CF; Gao ZY; Huang XK; Wang KD; Ye TW; Dai MG; Liu SY; Shen GL; Liu JW; Zhang CW; Huang DS
Asian J Surg; 2024 May; ():. PubMed ID: 38724372
[TBL] [Abstract][Full Text] [Related]
35. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
36. Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis.
Zhang XP; Chai ZT; Gao YZ; Chen ZH; Wang K; Shi J; Guo WX; Zhou TF; Ding J; Cong WM; Xie D; Lau WY; Cheng SQ
HPB (Oxford); 2019 Dec; 21(12):1687-1696. PubMed ID: 31153833
[TBL] [Abstract][Full Text] [Related]
37. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
[No Abstract] [Full Text] [Related]
38. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma.
Chen W; Ma T; Zhang J; Zhang X; Chen W; Shen Y; Bai X; Liang T
HPB (Oxford); 2020 Jun; 22(6):795-808. PubMed ID: 31980307
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion.
Qiu Y; Yang Y; Wang T; Shen S; Wang W
Front Oncol; 2022; 12():831614. PubMed ID: 35795039
[TBL] [Abstract][Full Text] [Related]
40. Postoperative Adjuvant Transarterial Chemoembolization Improves Outcomes of Hepatocellular Carcinoma Associated with Hepatic Vein Invasion: A Propensity Score Matching Analysis.
Zhang XP; Liu YC; Chen ZH; Sun JX; Wang K; Chai ZT; Shi J; Guo WX; Wu MC; Lau WY; Cheng SQ
Ann Surg Oncol; 2019 May; 26(5):1465-1473. PubMed ID: 30767178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
